Unicycive Therapeutics Inc (UNCY) is lower by Friday morning, with the stock losing -2.31% in pre-market trading to 2.11. UNCY's short-term technical score of 96 indicates that the stock has traded more bullishly over the last month than 96% of stocks on the market. In the Biotechnology industry, which ranks 110 out of 146 industries, Unicycive Therapeutics Inc ranks higher than 94% of stocks. Unicycive Therapeutics Inc has risen 300.00% over the past month, closing at $0.53 on February 17. During this period of time, the stock fell as low as $0.47 and as high as $2.87. UNCY has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.
UNCY has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on UNCY!